Stan Bernard, MD, MBA – President

  • President of Bernard Associates, LLC and competition consultant to nineteen of the top twenty global pharmaceutical companies and over 125 other leading health care product companies across six continents.
  • Simulated over 300 product launches involving 60 countries across six continents
  • Internationally-recognized, award-winning competitive competition consultant, speaker, and author for the pharmaceutical and health care industries
  • Former Senior Fellow at The Wharton School of Business where he initiated the Pharmaceutical Management MBA course and taught in the course for 14 years
  • Competition Columnist for two major industry journals, Pharmaceutical Executive and Pharmaceutical Executive Global Digest
  • Former Bristol-Myers Squibb Executive and Principal in A.T. Kearney’s Pharmaceutical Industry Consulting Practice
  • #1 Publisher of Pharmaceutical Competition articles in the world
  • Author, Brands Don’t Win: How Transcenders Change The Game

Stan Bernard, MD, MBA is President of Bernard Associates, the #1 Global Pharmaceutical Competition Consulting Firm. Dr. Bernard is internationally recognized as a pharmaceutical and healthcare industry competition consultant, speaker, and author. He has been featured on national television and in leading publications, including the Wall Street Journal, Business 2.0, and Business Week. Dr. Bernard has published the book Brands Don’t Win: How Transcenders Change The Game and over 75 book chapters, syndicated reports, and articles. He wrote two different columns on competition for the journals Pharmaceutical Executive and Pharmaceutical Executive Global Digest. Dr. Bernard has worked with nineteen of the top twenty global pharmaceutical companies and with over 125 other leading pharmaceutical and health care companies across six continents.


Dr. Bernard previously worked at Bristol-Myers Squibb Pharmaceutical Company where he held six different executive business and medical positions. He was U.S. Product Manager for the launch of the cholesterol-lowering drug Pravachol, the first Bristol-Myers Squibb pharmaceutical product ever to exceed $100 million in any worldwide market in its first year of sales. He served as U.S. Managed Care Medical Director, the first person to hold such a position in the pharmaceutical industry. Dr. Bernard was U.S. Director-Pharmacoeconomics, where he initiated and directed Bristol-Myers Squibb’s health/disease management initiatives. He co-initiated and helped direct the Medical Services Managers Program, the first doctor-only field based sales force in the U.S. pharmaceutical industry. He directed U.S. Medical Affairs for BMS’s infectious disease products and worked in Worldwide Licensing and Business Development.

Founder and President of Bernard Associates, Stan Bernard, MD, MBA, has been hailed as one of the most strategic, innovative consultants in the pharmaceutical industry… Dr. Bernard is nationally renowned as a healthcare and pharmaceutical industry guru. (PharmaVoice, August 2006)

Prior to joining Bristol-Myers Squibb, Dr. Bernard served as a Consulting Principal in the Pharmaceutical Industry Practice at A.T. Kearney. He worked at Mediq, Inc. as a Senior Health Care Consultant to hospital systems and physician group practices. For over a decade, Dr. Bernard served as an Expert Consultant to the U.S. Agency for Healthcare Research and Quality (AHRQ).

Professional Activities

For 14 years (1991-2005), Dr. Bernard was a Senior Fellow in the Healthcare Systems Department at The Wharton School of Business where he initiated and lectured in the “Pharmaceutical Management” MBA course. He also initiated and lectured in the “Healthcare Information Technology” MBA course for five years. From 1994-97, he was an Adjunct Professor at the Vanderbilt Owen School of Management where he lectured on Pharmaceutical Management. Dr. Bernard has conducted numerous presentations at executive business forums, national medical societies, governmental agencies, and academic institutions, including the Stanford School of Business, Columbia Business School, Harvard Medical School, and the Northwestern University Kellogg Business School.

Stan Bernard has successfully combined a medical degree, a Wharton MBA, and an entrepreneurial approach to consulting that has enabled him to work as a consultant, speaker, teacher, and published expert….Bernard has tackled opportunities at Fortune 500 companies and small startups alike, always bringing a sense of foresight and vision. Few people in the field today have his background; even fewer can reliably be called on to provide objective advice about a rapidly changing field and remain on the cutting edge.
(Advance Magazine, October 2000)

Dr. Bernard has won numerous awards for his work. In 2006, he was the first independent management consultant ever to be recognized for PharmaVoice Magazine’s “100 Most Inspiring People in the Pharmaceutical Industry.” In 2000, Dr. Bernard received the prestigious “Wharton School of Business Health Care Alumni Achievement Award” for contributions to the health care industry and to the Wharton School of Business Health Care Management MBA Program. He also received the “A.T. Kearney Global Intellectual Capital Recognition Award,” the highest individual honor awarded to an A.T. Kearney consultant worldwide in 1997.

Dr. Bernard was the founder and first Editor-in-Chief of Disease Management, the official journal of the Disease Management Association of America. Dr. Bernard has served on the boards of numerous companies, organizations, and journals, including Pharmaceutical Executive magazine, Morristown Medical Center (NJ), the Metro Chapter of the Healthcare Business Women’s (HBA) Association, and the Dorothy B. Hersh Foundation, which provides grants to help special needs and handicapped children in New Jersey.


Dr. Bernard received his M.B.A. in marketing and health care management from the Wharton School of Business. He received his Medical Degree from Baylor College of Medicine and is formerly a licensed general practitioner. He received his B.A. in biology (with a concentration in genetics) from the University of Pennsylvania and completed additional coursework at Edinburgh University in Scotland.